Ocugen to Spotlight Groundbreaking Retinal Disease Therapy at Retina World Congress
MALVERN, PA — Biopharmaceutical firm Ocugen, Inc. (NASDAQ: OCGN), today revealed that its Chief Scientific Officer and Head of Research & Development, Arun Upadhyay, PhD, is slated to speak at …
Ocugen to Spotlight Groundbreaking Retinal Disease Therapy at Retina World Congress Read More